ClinicalTrials.gg
Drug

Dexrazoxane clinical trials

Also written Zinecard, Totect, ADR-529 and ICRF-187.

studies test it
24
open now
3
in phase 3
7
first study started
1996

How each study uses Dexrazoxane is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Dexrazoxane studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 May 1995 · ZINECARD · NDA 020212 (FDA, Drugs@FDA)
European Union
27 Jul 2006 · Savene · EMEA/H/C/000682 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Dexrazoxane
13
dexrazoxane hydrochloride
10
NSC #169780
3
DZR
2

Brand

Zinecard
11
Totect
5
Cardioxane
3
Savene
1

Development codes

ADR-529
3
ICRF-187
3

Studies by the year they started

23 studies that test it; most in 2001 (3)

Studies that test Dexrazoxane, by start year
YearStudies
19961
19971
19981
19991
20013
20022
20031
20092
20121
20131
20141
20161
20182
20212
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
14
Phase 3
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 21

Children's Oncology Group (3) · National Cancer Institute (NCI) (2) · Valerio Therapeutics (2) · City of Hope Medical Center (2) · St. Jude Children's Research Hospital (1) · Rohan Dharmakumar (1) · University of Arkansas (1) · Washington University School of Medicine (1)

Often tested with

Tested in the same studies.

Doxorubicin (8) · Vincristine (4) · Irinotecan (3) · Cisplatin (3) · Ifosfamide (2) · Etoposide (2) · Cyclophosphamide (2) · Bevacizumab (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Dexrazoxane.

Studies

Open first, then newest update. How each study uses Dexrazoxane is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 24

See all 24 studies that test Dexrazoxane →

Given beside what is tested · 24 — Dexrazoxane is usual care or a partner of the new treatment

Showing 20 of 24.

As the comparator · 3 — what is tested is compared with Dexrazoxane

Codes

What other systems call Dexrazoxane · ClinicalTrials.gg INT008975

  • MeSH (NLM) D064730DexrazoxaneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 048L81261FDEXRAZOXANEConfirmed FDA, NLM, Wikidata
  • RxNorm 42736Confirmed FDA, Wikidata
  • Wikidata Q524995dexrazoxaneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1333DexrazoxaneOne source FDA
  • DrugBank DB00380One source Wikidata

Also registered as dexrazoxane hydrochloride (UNII 5346058Q7S · RxNorm 1294534).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.